Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Wisner Baum Warns: New Pesticide Immunity Laws Put Public Health and Corporate Accountability at Risk


News provided by

Wisner Baum

Aug 26, 2025, 14:21 ET

Share this article

Share toX

Share this article

Share toX

Wisner Baum, the law firm behind the groundbreaking jury verdict linking Monsanto's Roundup to non-Hodgkin's lymphoma, warns that new liability shield laws in North Dakota and Georgia will shut the courthouse doors to pesticide cancer victims. The firm alleges these laws would have stopped its landmark 2018 Monsanto case—preventing the public from ever seeing the now-infamous "Monsanto Papers."

LOS ANGELES, Aug. 26, 2025 /PRNewswire/ -- The law firm Wisner Baum LLP, nationally recognized for its groundbreaking legal victories against Monsanto regarding glyphosate-based herbicides, is sounding the alarm on new industry sponsored state and federal legislation that severely limits cancer victims' ability to hold pesticide manufacturers liable.

Continue Reading
"We need to keep asking why they are afraid of “failure to warn” labels and other forms of transparency and accountability,”  - Michael Baum, managing partner at Wisner Baum
"We need to keep asking why they are afraid of “failure to warn” labels and other forms of transparency and accountability,” - Michael Baum, managing partner at Wisner Baum

"This state legislation to shield pesticide manufacturers from lawsuits is a blow to corporate accountability. We need to keep asking why they are afraid of 'failure to warn' labels and other forms of transparency and accountability," questioned Michael Baum, managing partner at Wisner Baum and lead trial counsel in the Johnson case, referring to a spate of bills introduced to state legislatures.(1)

In 2018, Wisner Baum's trial team represented Dewayne "Lee" Johnson, a California school groundskeeper diagnosed with terminal non-Hodgkin lymphoma and secured the first-ever jury verdict linking Monsanto's Roundup weed-killer to cancer. The San Francisco jury awarded Johnson $289.2 million (later reduced to $20.5 million), finding Monsanto liable for failing to warn about the cancer risks of glyphosate.(2)

That case also unearthed the "Monsanto Papers"—internal corporate documents revealing ghostwritten studies, efforts to influence regulators, and attacks on independent scientists. (3) Johnson v. Monsanto became a watershed moment, sparking thousands of lawsuits, billions in settlements, and a worldwide reexamination of glyphosate safety.

New Threat: Liability Shield Laws

According to the Lawsuit Information Center, "Monsanto had settled nearly 100,000 Roundup lawsuits—paying about $11 billion—and an estimated 61,000 cases remain pending as of May 2025." (4) These figures give a glimpse of how many people have been affected by this pesticide exposure. 

Soon after the Johnson verdict, Brent Wisner, managing partner at Wisner Baum and lead trial counsel in the case said, "For the public at large, the lawsuit presented a question of corporate accountability. With enough money and influence, could a company endanger its customers, hide evidence, manipulate regulators, and get away with it all—for decades?" (5)

With these new liability shield laws, that question resurfaces. According to Wisner, the new laws enacted in North Dakota and Georgia could have stopped Johnson's case before it began. These statutes bar state-law "failure-to-warn" claims if a pesticide is registered with and approved by the U.S. Environmental Protection Agency (EPA), effectively giving manufacturers a pass if their label complies with federal rules—even if evidence suggests they withheld safety risks. 

In addition to state laws, Congress has introduced a pesticide immunity provision —Section 453 of the House Appropriations Bill—that would lock federal agencies and courts into outdated health assessments. Section 453 would effectively shield more than 57,000 currently registered products, and all future chemicals regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Earlier attempts to grant similar preemption to the Environmental Protection Agency (EPA) appeared in the House Farm Bill (2024) and the Agricultural Labeling Uniformity Act (2023). (6)

"If these laws had been in place in 2018, Johnson's case would have been thrown out before the first witness took the stand," said Baum. "There would have been no verdict, no Monsanto Papers, and no public reckoning. Corporate misconduct would have stayed hidden."

Justice Denied by Design, What's at Risk Beyond the Courtroom

For pesticide corporations, the new state legislation is about money, but for those harmed by pesticides, legal actions are not just about compensation. "Juries serve as a check when regulators fail," said Wisner. "These new laws take that check away." Here's what else is at stake:

  • No Day in Court: Under these laws, plaintiffs alleging pesticide-related cancers could see their cases dismissed outright if EPA-approved labels omit cancer warnings.
  • Evidence Locked Away: Internal corporate communications—often the key to proving liability—might never be unsealed.
  • Reduced Deterrence: Without the threat of punitive damages, there is less incentive for companies to disclose safety concerns.
  • Public Health Impact: Johnson's verdict was a catalyst for policy changes and restrictions on glyphosate worldwide.

Wisner Baum is urging lawmakers, advocates, and the public to understand the stakes as more states consider similar legislation.

About Wisner Baum

Wisner Baum began with a simple but radical idea: that the law should serve people—not protect power. Since opening its doors in 1985, the firm has gone far beyond courtroom victories. Based in Los Angeles and known across the U.S., Wisner Baum has built its legacy by holding powerful corporations accountable — not just to win justice for individual clients, but to spark broader societal change.

Every case they take on — from catastrophic injuries and pharmaceutical failures to environmental toxicity and corporate negligence — is part of a bigger mission: to make the world safer, more just, and more transparent for everyone. With over $4 billion in verdicts and settlements, their legal victories have helped raise public awareness, influence regulations, and force industries to clean up harmful practices. Their work has become a catalyst for product safety reforms, food transparency, and medical accountability.

Wisner Baum isn't just a law firm. It's a movement for change—where justice isn't the end goal, but the beginning of a safer society.

Wisner Baum: Changing the System for Societal Change, One Case at a Time.

Learn more at https://www.wisnerbaum.com.

References 

  1. Leggett, Vincent. "New Legislation Protects Pesticide Manufacturers from Legal Complaints of Harm." Food Tank, 29 May 2025, foodtank.com/news/2025/05/new-legislation-protects-pesticide-manufacturers-from-legal-complaints-of-harm/. 
  2. Johnson v. Monsanto Co. Opinion. Superior Court of California, County of San Francisco, No.CGC16550128, 10 Aug. 2018; decision modified by Court of Appeal, First Appellate District, 20 July 2020, 52 Cal. App. 5th 434.
  3. Gillam, Carey. The Monsanto Papers: Deadly Secrets, Corporate Corruption, and One Man's Search for Justice. Island Press, 2021.
  4. Lawsuit Information Center. "Monsanto Roundup Lawsuit Update." Lawsuit Information Center, May 2025, Lawsuit-Information-Center.com.
  5. Johnson v. Monsanto Co.: "Landmark Roundup Cancer Case." Wisner Baum, wisnerbaum.com/toxic-tort-law/monsanto-roundup-lawsuit/johnson-trial-2018-/.
  6. Heflin, Jason O. Preemption in the Federal Insecticide, Fungicide, and Rodenticide Act. Congressional Research Service, 2 May 2025, congress.gov/crs_external_products/LSB/PDF/LSB11304/LSB11304.1.pdf.

Media Inquiries: 
Karla Jo Helms 
JOTO PR ™ 
727-777-4629 
Jotopr.com

SOURCE Wisner Baum

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Wisner Baum Calls for FDA Accountability as Toxic Metals Remain in Baby Food Products

Wisner Baum Calls for FDA Accountability as Toxic Metals Remain in Baby Food Products

As the U.S. Food and Drug Administration (FDA) prepares to release its next progress report on the "Closer to Zero" initiative to protect children...

Wisner Baum: Ninth Circuit Affirms Actos RICO Class Action Certification Against Takeda and Eli Lilly

Wisner Baum: Ninth Circuit Affirms Actos RICO Class Action Certification Against Takeda and Eli Lilly

The U.S. Court of Appeals for the Ninth Circuit affirmed a class certification order in Painters & Allied Trades District Council 82 Health Care Fund ...

More Releases From This Source

Explore

Advocacy Group Opinion

Advocacy Group Opinion

Legal Issues

Legal Issues

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.